Brexit: Severe Risks to Britain’s National Health Service

• Published in: American journal of public health (1971) Vol. 107; no. 10; pp. 1594 - 1596
• Main Authors: Park, John J., McKee, Martin, Atun, Rifat
• Format: Journal Article
• Language: English
• Published: United States American Public Health Association 01.10.2017
• Subjects: AJPH s; Chemicals; Climate change; Clinical trials; Delivery of Health Care - economics; Delivery of Health Care - legislation & jurisprudence; Developing countries; Disputes; Drug and Narcotic Control - economics; Drug and Narcotic Control - legislation & jurisprudence; Drug withdrawal; Drugs; EU membership; European Union - history; FDA approval; Federal regulation; Food safety; Global Health; Health care access; Health Policy; Health Policy - economics; Health Policy - legislation & jurisprudence; Health Reform; Health services; History, 21st Century; Human tissues; Humans; Immunization; Immunosuppressive agents; Innovations; International trade; LDCs; Legislatures; Marketing; Medical equipment; Medical research; Negotiation; Organic chemistry; Organs; Parliamentary committees; Parliaments; Patient safety; Pharmaceutical industry; Politics; Public health; Quality of care; R&D; Referendums; Regulations; Regulatory agencies; Regulatory approval; Research & development; Safety; Safety management; State Medicine - economics; State Medicine - legislation & jurisprudence; Tobacco; Transplantation; United Kingdom; Vaccines; Waste management; Water quality; Workforce; United Kingdom; United Kingdom > UK

A document purporting to set out its plan was a list of vague aspirations, lacking any recognition of the need to negotiate future arrangements with the remaining 27 EU member states and the European Parliament. Switzerland- a non-EU country with significant pharmaceutical manufacturing-typically wa...